拮抗剂-话题@MedSci

#拮抗剂#

223篇内容 | 4281人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1511781, encodeId=bf551511e819c, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Heart：真实世界分析全新结果，再次证实了非维生素K拮抗剂口服抗凝剂的临床获益及安全性, objectType=article, longId=207716, objectId=b66220e716e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b66220e716e3, replyNumber=0, likeNumber=80, createdTime=2021-03-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b66220e716e3, moduleTitle=Heart：真实世界分析全新结果，再次证实了非维生素K拮抗剂口服抗凝剂的临床获益及安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b66220e716e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511780, encodeId=0fd21511e8051, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=NEJM：反转！白介素-6受体拮抗剂可改善危重症新冠肺炎患者预后！, objectType=article, longId=207688, objectId=9db020e68829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9db020e68829, replyNumber=0, likeNumber=114, createdTime=2021-02-28, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9db020e68829, moduleTitle=NEJM：反转！白介素-6受体拮抗剂可改善危重症新冠肺炎患者预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9db020e68829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511779, encodeId=54e61511e7936, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=AP&T: 直接口服抗凝药和维生素K拮抗剂在导致上消化道出血的危险性中的比较, objectType=article, longId=207326, objectId=754320e3263d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=754320e3263d, replyNumber=0, likeNumber=65, createdTime=2021-02-21, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=754320e3263d, moduleTitle=AP&T: 直接口服抗凝药和维生素K拮抗剂在导致上消化道出血的危险性中的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=754320e3263d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511778, encodeId=b7fe1511e78d6, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JAHA：服用非维生素K拮抗剂口服抗凝剂的房颤患者患痴呆症风险更低, objectType=article, longId=207183, objectId=ea2d20e18342, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea2d20e18342, replyNumber=0, likeNumber=87, createdTime=2021-02-18, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea2d20e18342, moduleTitle=JAHA：服用非维生素K拮抗剂口服抗凝剂的房颤患者患痴呆症风险更低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea2d20e18342)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511777, encodeId=0e151511e77b3, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Hypertension：盐皮质激素受体拮抗剂对动脉僵硬度和内皮功能的影响, objectType=article, longId=206691, objectId=4e2a2066913a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e2a2066913a, replyNumber=0, likeNumber=72, createdTime=2021-02-04, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e2a2066913a, moduleTitle=Hypertension：盐皮质激素受体拮抗剂对动脉僵硬度和内皮功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e2a2066913a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511776, encodeId=45321511e769d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Stroke：既往有胃肠道出血的房颤患者非维生素K拮抗剂口服抗凝剂疗效分析, objectType=article, longId=205797, objectId=b852205e97eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b852205e97eb, replyNumber=0, likeNumber=89, createdTime=2021-01-18, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b852205e97eb, moduleTitle=Stroke：既往有胃肠道出血的房颤患者非维生素K拮抗剂口服抗凝剂疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b852205e97eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511775, encodeId=5eba1511e7559, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=JACC：美英法跨国研究 | 盐皮质激素受体拮抗剂治疗心衰患者的疗效, objectType=article, longId=205313, objectId=56fa20531308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56fa20531308, replyNumber=0, likeNumber=86, createdTime=2021-01-06, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56fa20531308, moduleTitle=JACC：美英法跨国研究 | 盐皮质激素受体拮抗剂治疗心衰患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=56fa20531308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511774, encodeId=07101511e74a0, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=FDA批准口服GnRH受体拮抗剂Orgovyx治疗晚期前列腺癌, objectType=article, longId=204709, objectId=0a77204e09af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a77204e09af, replyNumber=0, likeNumber=59, createdTime=2020-12-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a77204e09af, moduleTitle=FDA批准口服GnRH受体拮抗剂Orgovyx治疗晚期前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a77204e09af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511773, encodeId=90421511e735e, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=新型LAIR1拮抗剂NGM438，或可用于治疗晚期实体瘤, objectType=article, longId=204375, objectId=639c2043e5d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=639c2043e5d0, replyNumber=0, likeNumber=52, createdTime=2020-12-12, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=639c2043e5d0, moduleTitle=新型LAIR1拮抗剂NGM438，或可用于治疗晚期实体瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=639c2043e5d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511772, encodeId=64971511e7203, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=前列腺素F2受体拮抗剂ebopiprant：治疗48小时内将早产率降低55％, objectType=article, longId=203526, objectId=70fd20352693, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70fd20352693, replyNumber=0, likeNumber=64, createdTime=2020-11-20, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70fd20352693, moduleTitle=前列腺素F2受体拮抗剂ebopiprant：治疗48小时内将早产率降低55％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70fd20352693)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511771, encodeId=9b711511e7174, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Heart：房颤患者非维生素K拮抗剂停药特征, objectType=article, longId=202259, objectId=5b9b20225968, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b9b20225968, replyNumber=0, likeNumber=94, createdTime=2020-10-20, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b9b20225968, moduleTitle=Heart：房颤患者非维生素K拮抗剂停药特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b9b20225968)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511770, encodeId=21361511e70bb, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=更年期女性血管舒缩症状（VMS）：选择性NK3R拮抗剂MLE-301进入临床试验, objectType=article, longId=201327, objectId=1f2c20132e3c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f2c20132e3c, replyNumber=0, likeNumber=48, createdTime=2020-09-30, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f2c20132e3c, moduleTitle=更年期女性血管舒缩症状（VMS）：选择性NK3R拮抗剂MLE-301进入临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f2c20132e3c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511769, encodeId=3ac91511e693d, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Clin Gastroenterology H：肿瘤坏死因子拮抗剂在原发性硬化性胆管炎患者中的作用分析, objectType=article, longId=200065, objectId=c6ab2000650f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c6ab2000650f, replyNumber=0, likeNumber=85, createdTime=2020-09-01, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c6ab2000650f, moduleTitle=Clin Gastroenterology H：肿瘤坏死因子拮抗剂在原发性硬化性胆管炎患者中的作用分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c6ab2000650f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511768, encodeId=75d11511e68f9, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Prostate Cancer P D：前列腺癌患者的心脏标记和接受促性腺激素释放激素激动剂与拮抗剂患者的心血管疾病研究, objectType=article, longId=199759, objectId=d24f199e5947, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24f199e5947, replyNumber=0, likeNumber=69, createdTime=2020-08-22, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24f199e5947, moduleTitle=Prostate Cancer P D：前列腺癌患者的心脏标记和接受促性腺激素释放激素激动剂与拮抗剂患者的心血管疾病研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24f199e5947)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511767, encodeId=59311511e6798, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=EUR HEART J-CARD PHA：房颤患者同时服用非维生素K拮抗剂、口服抗凝剂和抗癫痫药物的重大出血风险？, objectType=article, longId=198583, objectId=a203198583fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a203198583fe, replyNumber=0, likeNumber=71, createdTime=2020-08-03, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a203198583fe, moduleTitle=EUR HEART J-CARD PHA：房颤患者同时服用非维生素K拮抗剂、口服抗凝剂和抗癫痫药物的重大出血风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a203198583fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511766, encodeId=f5071511e66b8, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Reprod Biol Endocrinol：拮抗剂周期的黄体期添加三妥瑞林可优化ART的结局, objectType=article, longId=198012, objectId=9b7d19801284, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b7d19801284, replyNumber=0, likeNumber=76, createdTime=2020-07-26, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b7d19801284, moduleTitle=Reprod Biol Endocrinol：拮抗剂周期的黄体期添加三妥瑞林可优化ART的结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b7d19801284)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511765, encodeId=8acb1511e6519, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Gastroenterology：速激肽受体1的拮抗剂(Tradipitant)对糖尿病和特发性胃轻瘫患者的疗效分析, objectType=article, longId=197752, objectId=aaf119e752e4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aaf119e752e4, replyNumber=0, likeNumber=82, createdTime=2020-07-21, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aaf119e752e4, moduleTitle=Gastroenterology：速激肽受体1的拮抗剂(Tradipitant)对糖尿病和特发性胃轻瘫患者的疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aaf119e752e4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511764, encodeId=02531511e6496, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=J Urol：GnRH激动剂 VS拮抗剂在晚期前列腺癌和心血管疾病患者中的心血管发病率, objectType=article, longId=197429, objectId=877719e4295d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=877719e4295d, replyNumber=0, likeNumber=61, createdTime=2020-07-14, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=877719e4295d, moduleTitle=J Urol：GnRH激动剂 VS拮抗剂在晚期前列腺癌和心血管疾病患者中的心血管发病率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=877719e4295d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511763, encodeId=00df1511e6342, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=GnRH拮抗剂linzagolix治疗子宫肌瘤，3期研究取得积极成果, objectType=article, longId=197183, objectId=509719e18322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=509719e18322, replyNumber=0, likeNumber=60, createdTime=2020-07-09, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=509719e18322, moduleTitle=GnRH拮抗剂linzagolix治疗子宫肌瘤，3期研究取得积极成果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=509719e18322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1511762, encodeId=93231511e626b, content=<a href='/topic/show?id=90d75628960' target=_blank style='color:#2F92EE;'>#拮抗剂#</a>, objectTitle=Nat Med：胰腺癌治疗新进展！CXCR4拮抗剂+PD-1抑制剂+化疗的三联疗法，初步试验中疾病控制率达77%, objectType=article, longId=194894, objectId=3a80194894a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a80194894a3, replyNumber=0, likeNumber=34, createdTime=2020-05-29, rootId=0, userName=ms5236388012055669, userId=474c10379153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a80194894a3, moduleTitle=Nat Med：胰腺癌治疗新进展！CXCR4拮抗剂+PD-1抑制剂+化疗的三联疗法，初步试验中疾病控制率达77%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a80194894a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

拮抗剂

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#拮抗剂#

Heart：真实世界分析全新结果，再次证实了非维生素K拮抗剂口服抗凝剂的临床获益及安全性

2021-03-01

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

NEJM：反转！白介素-6受体拮抗剂可改善危重症新冠肺炎患者预后！

2021-02-28

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

AP&T: 直接口服抗凝药和维生素K拮抗剂在导致上消化道出血的危险性中的比较

2021-02-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JAHA：服用非维生素K拮抗剂口服抗凝剂的房颤患者患痴呆症风险更低

2021-02-18

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Hypertension：盐皮质激素受体拮抗剂对动脉僵硬度和内皮功能的影响

2021-02-04

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Stroke：既往有胃肠道出血的房颤患者非维生素K拮抗剂口服抗凝剂疗效分析

2021-01-18

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

JACC：美英法跨国研究 | 盐皮质激素受体拮抗剂治疗心衰患者的疗效

2021-01-06

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

FDA批准口服GnRH受体拮抗剂Orgovyx治疗晚期前列腺癌

2020-12-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

新型LAIR1拮抗剂NGM438，或可用于治疗晚期实体瘤

2020-12-12

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

前列腺素F2受体拮抗剂ebopiprant：治疗48小时内将早产率降低55％

2020-11-20

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Heart：房颤患者非维生素K拮抗剂停药特征

2020-10-20

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

更年期女性血管舒缩症状（VMS）：选择性NK3R拮抗剂MLE-301进入临床试验

2020-09-30

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Clin Gastroenterology H：肿瘤坏死因子拮抗剂在原发性硬化性胆管炎患者中的作用分析

2020-09-01

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Prostate Cancer P D：前列腺癌患者的心脏标记和接受促性腺激素释放激素激动剂与拮抗剂患者的心血管疾病研究

2020-08-22

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

EUR HEART J-CARD PHA：房颤患者同时服用非维生素K拮抗剂、口服抗凝剂和抗癫痫药物的重大出血风险？

2020-08-03

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Reprod Biol Endocrinol：拮抗剂周期的黄体期添加三妥瑞林可优化ART的结局

2020-07-26

柳叶一刀 (审核中...)

前往app查看评论内容

#拮抗剂#

Gastroenterology：速激肽受体1的拮抗剂(Tradipitant)对糖尿病和特发性胃轻瘫患者的疗效分析

2020-07-21

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

J Urol：GnRH激动剂 VS拮抗剂在晚期前列腺癌和心血管疾病患者中的心血管发病率

2020-07-14

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

GnRH拮抗剂linzagolix治疗子宫肌瘤，3期研究取得积极成果

2020-07-09

ms5236388012055669 (审核中...)

前往app查看评论内容

#拮抗剂#

Nat Med：胰腺癌治疗新进展！CXCR4拮抗剂+PD-1抑制剂+化疗的三联疗法，初步试验中疾病控制率达77%

2020-05-29

科室
- - 订阅+
  - 更多科室
工具
服务